Studies have shown that RIPK4 is upregulated in nasopharyngeal carcinoma tissues and facilitates the progression of tumours by promoting the expression of VEGF in nasopharyngeal carcinoma cells (Yongqian et al., 2018). This evidence concerns the gene RIPK4 and neoplasm.